Review



matlab toolbox-leaddbs  (MathWorks Inc)


Bioz Verified Symbol MathWorks Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    MathWorks Inc matlab toolbox-leaddbs
    a DBS lead construction via <t>LeadDBS</t> toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.
    Matlab Toolbox Leaddbs, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 258 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matlab toolbox-leaddbs/product/MathWorks Inc
    Average 96 stars, based on 258 article reviews
    matlab toolbox-leaddbs - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease"

    Article Title: Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease

    Journal: NPJ Parkinson's Disease

    doi: 10.1038/s41531-024-00668-4

    a DBS lead construction via LeadDBS toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.
    Figure Legend Snippet: a DBS lead construction via LeadDBS toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.

    Techniques Used: Expressing, Standard Deviation



    Similar Products

    matlab toolbox-leaddbs  (MathWorks Inc)
    96
    MathWorks Inc matlab toolbox-leaddbs
    a DBS lead construction via <t>LeadDBS</t> toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.
    Matlab Toolbox Leaddbs, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/matlab toolbox-leaddbs/product/MathWorks Inc
    Average 96 stars, based on 1 article reviews
    matlab toolbox-leaddbs - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    leaddbs matlab toolbox  (MathWorks Inc)
    90
    MathWorks Inc leaddbs matlab toolbox
    a DBS lead construction via <t>LeadDBS</t> toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.
    Leaddbs Matlab Toolbox, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/leaddbs matlab toolbox/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    leaddbs matlab toolbox - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    a DBS lead construction via LeadDBS toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.

    Journal: NPJ Parkinson's Disease

    Article Title: Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease

    doi: 10.1038/s41531-024-00668-4

    Figure Lengend Snippet: a DBS lead construction via LeadDBS toolbox. Bilateral DBS leads accurately targeted the STN region (orange area). b , c The SOD level was obviously increased after patients received STN-DBS for six months ( P = 0.0455), nevertheless, GSH expression did not change in the same period ( P = 0.3025) ( n = 8 per time point; paired-T test). d , e Regardless of whether patients were on or off medication, the MDS-UPDRS III scores were significantly reduced after the operation ( n = 7 per time point; d: P = 0.0329; e: P = 0.0002; paired-T test). f , g There was no significant relationship between changes in antioxidant enzymes [SOD ( P = 0.8763) or GSH ( P = 0.7926)] and change in MDS-UPDRS III ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\frac{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}-{({Postoperative}\,{MDS}\,{UPDRS})}_{{stm}-{on},\,{med}-{off}}}{{({Preoperative}\,{\rm{MDS}}-{\rm{UPDRS}})}_{{med}-{off}}}\times 100 \%$$\end{document} ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f − ( P o s t o p e r a t i v e M D S U P D R S ) s t m − o n , m e d − o f f ( P r e o p e r a t i v e MDS − UPDRS ) m e d − o f f × 100 % ) ( n = 7; Pearson correlation test). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Error bars standard deviation of the mean, STN-DBS subthalamic nuclei deep brain stimulation, PD Parkinson’s disease, SOD superoxide dismutase, GSH glutathione, MDS-UPDRS Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale, ns not significant.

    Article Snippet: The lead positions in PD patients were confirmed with a MATLAB toolbox-LeadDBS (v2.1.8, https://www.lead-dbs.org ) via fusion of preoperative magnetic resonance imaging (MRI) and postoperative computed tomography (CT) , the results showed that the leads were accurately implanted into the STN (Fig. ).

    Techniques: Expressing, Standard Deviation